{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:04:33Z","timestamp":1789581873971,"version":"build-2803163510"},"reference-count":18,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    Fabry disease (FD) is the most common lysosomal storage disorder in which a severe, classical phenotype as well as a milder, non-classical phenotype can be distinguished. In this study we investigated the impact of the introduction of broader DNA sequencing techniques and subsequently the addition of the GLA-gene to NGS or WES based panels on the type of FD patient that is diagnosed by analyzing changes in the composition of the Dutch Fabry cohort over time. The current study confirms that Fabry disease is a genetically heterogeneous disorder with 64 different\n                    <jats:italic>GLA<\/jats:italic>\n                    variants established in a cohort of 319 patients. The introduction of broader DNA sequencing techniques, applied to a broader range of individuals with less specific symptoms, results in the identification of a higher proportion of individuals with less deleterious GLA variants and consequently a milder clinical phenotype. For the majority of individuals identified using the broader sequencing techniques cardiomyopathy is the presenting and only symptom of the disorder, in contrast to the multisystem classical Fabry disease phenotype. This phenotypic shift should be taken into account when comparing current to historical clinical and treatment effect data and requires tailored genetic counseling and clinical follow-up to prevent both over- and undertreatment.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0358572","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:31:26Z","timestamp":1789579886000},"page":"e0358572","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["The changing landscape of Fabry disease: Impact of the inclusion of the GLA-gene in broader NGS or WES based panels on the phenotypic spectrum"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6539-531X","authenticated-orcid":true,"given":"Laura","family":"van Dussen","sequence":"first","affiliation":[{"name":"Amsterdam UMC, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, University of Amsterdam","place":["Amsterdam, The Netherlands"],"department":["Department of Endocrinology and Metabolism"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1380-6673","authenticated-orcid":true,"given":"Emilie V.","family":"Albers","sequence":"additional","affiliation":[{"name":"Amsterdam UMC, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, University of Amsterdam","place":["Amsterdam, The Netherlands"],"department":["Department of Endocrinology and Metabolism"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8619-1511","authenticated-orcid":true,"given":"Saskia N.","family":"van der Crabben","sequence":"additional","affiliation":[{"name":"Maastricht University Medical Center","place":["Maastricht, The Netherlands"],"department":["Department of Clinical Genetics"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4687-0186","authenticated-orcid":true,"given":"Ronald H.","family":"Lekanne Deprez","sequence":"additional","affiliation":[{"name":"Amsterdam UMC, University of Amsterdam","place":["Amsterdam, The Netherlands"],"department":["Department of Clinical Genetics"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4903-8232","authenticated-orcid":true,"given":"Astrid S.","family":"Plomp","sequence":"additional","affiliation":[{"name":"Amsterdam UMC, University of Amsterdam","place":["Amsterdam, The Netherlands"],"department":["Department of Clinical Genetics"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9934-6831","authenticated-orcid":true,"given":"Mirjam","family":"Langeveld","sequence":"additional","affiliation":[{"name":"Amsterdam UMC, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, University of Amsterdam","place":["Amsterdam, The Netherlands"],"department":["Department of Endocrinology and Metabolism"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"issue":"10","key":"pone.0358572.ref001","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00439-020-02199-3","article-title":"The Human Gene Mutation Database (HGMD(R)): optimizing its use in a clinical diagnostic or research setting","volume":"139","author":"PD Stenson","year":"2020","journal-title":"Human Genetics"},{"issue":"10","key":"pone.0358572.ref002","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.2215\/CJN.0000000000000239","article-title":"Early risk stratification for natural disease course in Fabry patients using plasma globotriaosylsphingosine levels","volume":"18","author":"SJ van der Veen","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"issue":"23","key":"pone.0358572.ref003","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1136\/heartjnl-2020-317922","article-title":"Influence of sex and phenotype on cardiac outcomes in patients with Fabry disease","volume":"107","author":"M El Sayed","year":"2021","journal-title":"Heart"},{"issue":"2","key":"pone.0358572.ref004","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ijcard.2014.09.001","article-title":"Uncertain diagnosis of Fabry disease: consensus recommendation on diagnosis in adults with left ventricular hypertrophy and genetic variants of unknown significance","volume":"177","author":"BE Smid","year":"2014","journal-title":"Int J Cardiol"},{"key":"pone.0358572.ref005","first-page":"83","article-title":"Uncertain diagnosis of fabry disease in patients with neuropathic pain, angiokeratoma or cornea verticillata: consensus on the approach to diagnosis and follow-up","volume":"17","author":"L van der Tol","year":"2014","journal-title":"JIMD Rep"},{"issue":"10","key":"pone.0358572.ref006","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/humu.22368","article-title":"Best practice guidelines for the use of next-generation sequencing applications in genome diagnostics: a national collaborative study of Dutch genome diagnostic laboratories","volume":"34","author":"MM Weiss","year":"2013","journal-title":"Hum Mutat"},{"issue":"12","key":"pone.0358572.ref007","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/gim.2016.55","article-title":"Is it Fabry disease?","volume":"18","author":"R Schiffmann","year":"2016","journal-title":"Genet Med"},{"key":"pone.0358572.ref008"},{"issue":"1","key":"pone.0358572.ref009","article-title":"The impact of cardiovascular risk factors in non-classical Fabry disease","volume":"21","author":"BCF Veldman","year":"2026","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"pone.0358572.ref010","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/cge.14102","article-title":"Challenging the traditional approach for interpreting genetic variants: lessons from Fabry disease","volume":"101","author":"DP Germain","year":"2022","journal-title":"Clin Genet"},{"issue":"3","key":"pone.0358572.ref011","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41431-024-01657-0","article-title":"GLA insufficiency should not be called Fabry disease","volume":"33","author":"G Houge","year":"2025","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"pone.0358572.ref012","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13023-020-1297-9","article-title":"Molecular basis of Leigh syndrome: a current look","volume":"15","author":"M Schubert Baldo","year":"2020","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"pone.0358572.ref013","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1161\/CIRCGEN.119.002803","article-title":"Long-term follow-up study on the uptake of genetic counseling and predictive DNA testing in inherited cardiac conditions","volume":"13","author":"LM van den Heuvel","year":"2020","journal-title":"Circ Genom Precis Med"},{"issue":"12","key":"pone.0358572.ref014","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1136\/heartjnl-2023-323783","article-title":"Incidence and risk factors for development of left ventricular hypertrophy in Fabry disease","volume":"110","author":"E Monda","year":"2024","journal-title":"Heart"},{"issue":"1","key":"pone.0358572.ref015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmedgenet-2013-101857","article-title":"A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance","volume":"51","author":"L van der Tol","year":"2014","journal-title":"J Med Genet"},{"issue":"10","key":"pone.0358572.ref016","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1159\/000543920","article-title":"Further clinical and biochemical phenotype of GLA p.A143T: a Fabry disease newborn screening experience","volume":"149","author":"A Paltzer","year":"2025","journal-title":"Nephron"},{"key":"pone.0358572.ref017","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkt1113","article-title":"ClinVar: public archive of relationships among sequence variation and human phenotype","volume":"42","author":"MJ Landrum","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"pone.0358572.ref018","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2133.1970.tb06828.x","article-title":"Fabry\u2019s disease in children","volume":"82","author":"WP De Groot","year":"1970","journal-title":"Br J Dermatol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0358572","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:31:30Z","timestamp":1789579890000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0358572"}},"subtitle":[],"editor":[{"given":"Maria de F\u00e1tima Matos Almeida Henriques de","family":"Macedo","sequence":"first","affiliation":[{"name":"Universidade do Algarve","place":["PORTUGAL"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":18,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0358572","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]}}}